Sector Alpha Week of 2026-07-31
Sector Alpha — machine-written from the numbers · Data as of 2026-07-31

Welspun Specialty Solutions Ltd

WELSPLSOL
Steel - Tubes/Pipes

Welspun Specialty Solutions Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the price is already 13 weeks into its uptrend — timing risk, not thesis risk.

The price is in a confirmed uptrend (13 weeks in) while the P/E sits at the 59th percentile of its own 3-year range. Underneath, the last four quarters read mixed, and 100% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.

Price
₹51.0
+55.7% 1Y
P/E
118.0×
59th pctile
of its own 3-year range
Revenue (Jun 26)
₹194 Cr
−3.8% YoY
Profit (Jun 26)
₹5.2 Cr
Operating margin
5.4%
+3.3 pp YoY
ROCE
10%
FY26
ROIC
10.6%
vs WACC 12.0% → −1.4 pp
Cash conversion
100%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Welspun Specialty Solutions Ltd trades at ₹51.0, in a confirmed uptrend and 13 weeks into that stage. That is +18.6% against its own 200-day average. It sits at 68% of a 52-week range of ₹32 to ₹60. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (1 week and counting).

Today the stock is in a confirmed uptrend — week 13 of stage 2, confirmed. At ₹51.0 it trades +18.6% versus its 200-day average and sits at 68% of its 52-week range (₹32–₹60).

Jul 26: ₹51.0 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
+18.6% versus the 200-day line, week 13 of stage 2
Price50-day avg200-day avg
S2S4S2S2₹63.2₹51.5₹39.8₹28.1₹16.4₹51₹43Jul 23May 24Feb 25Nov 25Jul 26
S2S4S2S2₹63.2₹51.5₹39.8₹28.1₹16.4₹51₹43Jul 23Feb 25Jul 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (549 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Jul 26

Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +1,362% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (1 week and counting; last ahead the week of 2026-07-24) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Welspun Specialty Solutions Ltd trades at 118.0× P/E, mid-range by its own standards (59th percentile). Its long-run median P/E is 104.5×, measured across 3.0 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 118.0× is mid-range by its own standards (59th percentile), against a long-run median of 104.5× measured over 3.0 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 118.0× vs a 104.5× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 3.0-year window; loss-period spikes above 313× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
mid-range by its own standards (59th percentile)
P/EMedianEPS (TTM) (quarterly)
335.6×₹1.0255.3×₹0.8174.9×₹0.594.6×₹0.314.3×₹0.0×118.70×₹0Jul 23Mar 24Nov 24Jan 26Jul 26
335.6×₹1.0255.3×₹0.8174.9×₹0.594.6×₹0.314.3×₹0.0×118.70×₹0Jul 23Nov 24Jul 26
P/E
118.0×
59th percentile of 3y
PEG
n/m
not derivable — 3-year earnings growth unavailable

The price move, decomposed: over 3y, of the +20.5%/yr price move, ~+75.2%/yr came from earnings growth and ~−54.7 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Welspun Specialty Solutions Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 2 curves, on partial evidence.

Growth, year by year: revenue +22.4% in FY26 Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
174%−104%109%−112%44%−121%−21%−129%−86%−137%%%22.4%−106.5%FY16FY21FY26
174%−104%109%−112%44%−121%−21%−129%−86%−137%%%22.4%−106.5%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue stabilising
RevenueProfitEPS
121%333%88%213%55%93%22%−27%−10%−147%%%15.2%−31.4%−31.3%Sep 23Dec 24Jun 26
121%333%88%213%55%93%22%−27%−10%−147%%%15.2%−31.4%−31.3%Sep 23Dec 24Jun 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
27%23%18%14%9.1%%10.4%Sep 23Mar 24Dec 24Sep 25Jun 26
27%23%18%14%9.1%%10.4%Sep 23Dec 24Jun 26
Revenue growth
Rolling over
latest +15.2% · span −1.2% to +111.5%
ROCE
Falling
latest 10.4% · span 10.4%–26.2%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+22.4%+28.5%+57.0%+12.7%
Profit−24.4%
EPS−24.8%
Share price+55.7%+20.5%+22.6%+31.3%
Revenue YoY (Jun 26)
−3.8%
latest quarter vs a year ago
Revenue 10y
12.7%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

50.5/100 — rank 9 of 15 in Steel - Tubes/Pipes · 74% evidence confidence

Welspun Specialty Solutions Ltd scores 50.5 out of 100 against the 15 companies it is compared with in Steel - Tubes/Pipes, ranking 9. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 20.3 + 4.9 + 8.5 + 16.8 = 50.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Welspun Specialty Solutions Ltd reported ₹194 Cr of revenue in the Jun 26 quarter, −3.8% year on year. Over 10 years it has compounded at 12.7% a year. The last full year, FY26, came in at ₹886 Cr. The last four reported quarters add to ₹879 Cr.

FY26 revenue came in at ₹886 Cr (+22.4% on the year), capping 10 years at 12.7% compound. The latest quarter (Jun 26) printed ₹194 Cr, −3.8% year on year.

FY26 revenue ₹886 Cr (+22.4% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
12.7% a year over 10 years
RevenueYoY growth
957174%718109%47844%239−21%0−86%₹ Cr%₹88622.4%FY16FY21FY26
957174%718109%47844%239−21%0−86%₹ Cr%₹88622.4%FY16FY21FY26
Jun 26: ₹194 Cr (−3.8% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
258152%194106%12960%6514%0−32%₹ Cr%₹194−3.8%Sep 23Dec 24Jun 26
258152%194106%12960%6514%0−32%₹ Cr%₹194−3.8%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +16.3% growth against the decade's 12.7% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +15.2% over the last 4 quarters against +12.4%/yr over the last 8 — stabilising.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Welspun Specialty Solutions Ltd's operating margin is 5.4% in the Jun 26 quarter, +3.3 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −24.0% to 8.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 5.4%, +3.3 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −24.0%–8.0%.

Why the margin moved: operating margin went +3.3 pp year on year while gross margin went +6.6 pp — the gain came mostly from the gross line: input costs and pricing.

FY26: 5.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a −24.0–8.0% band over 13 years
operating marginYoY change (pp)
11%17%1.3%8.5%−8.0%−0.5%−17%−9.5%−27%−18%%%5%0.7%FY14FY20FY26
11%17%1.3%8.5%−8.0%−0.5%−17%−9.5%−27%−18%%%5%0.7%FY14FY20FY26
Jun 26: 5.4% operating margin (+3.3 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
8.5%5.2%6.7%2.3%4.8%−0.5%3.0%−3.4%1.1%−6.3%%%5.4%3.3%Sep 23Dec 24Jun 26
8.5%5.2%6.7%2.3%4.8%−0.5%3.0%−3.4%1.1%−6.3%%%5.4%3.3%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Welspun Specialty Solutions Ltd earned ₹5.2 Cr of net profit in the Jun 26 quarter. Full-year FY26 profit was ₹23.0 Cr. That is 2.7% of the quarter's revenue. The same quarter a year earlier lost ₹0.8 Cr. 3 of the last 12 reported quarters were loss-making.

Jun 26 profit was ₹5.2 Cr, null year on year. On the full year, FY26 printed ₹23.0 Cr (null).

FY26 profit ₹23.0 Cr (null YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
Net profitYoY growth
107−104%56−112%6−120%−44−129%−95−137%₹ Cr%₹23−106.5%FY16FY21FY26
107−104%56−112%6−120%−44−129%−95−137%₹ Cr%₹23−106.5%FY16FY21FY26
Jun 26: ₹5.2 Cr (null YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
44446%30267%1787%3−92%−10−272%₹ Cr%₹519.7%Sep 23Dec 24Jun 26
44446%30267%1787%3−92%−10−272%₹ Cr%₹519.7%Sep 23Dec 24Jun 26
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 100% of Welspun Specialty Solutions Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹128 Cr of operating cash against ₹23.0 Cr of profit. After ₹71.0 Cr of capital spending, ₹57.0 Cr was left as free cash.

FY26: operating cash of ₹128 Cr against reported profit of ₹23.0 Cr, leaving free cash of ₹57.0 Cr after ₹71.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 100% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹128 Cr vs profit ₹23.0 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution. FY19 reflects an acquisition year — point shown clipped.
100% of 3-year profit arrived as cash
Operating cashNet profitFree cash
1458321−42−104₹ Cr₹128₹23₹57FY16FY21FY26
1458321−42−104₹ Cr₹128₹23₹57FY16FY21FY26
FY26: CFO = 557% of profit (three-year rate 100%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash; outlier years shown pinned.
Conversion100%
323%239%156%72%−12%%300%FY16FY21FY26
323%239%156%72%−12%%300%FY16FY21FY26

Why conversion sits at 100%: the cash cycle tightened 263 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner.

Router verdict: the bigger cash user is investment — capital spending ran 1.9× depreciation over three years, so the next section's job is to check what that build-out is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Welspun Specialty Solutions Ltd's cash conversion cycle runs −2 days in FY26, down from 261 days in FY21. Capital spending ran ₹91.0 Cr over the last 3 years. At FY26 sales of ₹886 Cr each day of that cycle holds about ₹2.4 Cr, so roughly ₹−5.0 Cr sits inside the business at any moment.

FY26: debtors at 59 days, inventory at 153 days — roughly 5.0 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of −2 days, tighter than FY21's 261.

The full loop: cash goes out to suppliers and production on day 0; stock waits 153 days to sell; customers pay about 59 days after that; and suppliers themselves are paid at 214 days — netting out to the −2-day cycle.

In money terms: at FY26 sales of ₹886 Cr, each day of the cycle holds about ₹2.4 Cr — so the −2-day loop keeps roughly ₹−5.0 Cr sitting inside the business at any moment.

FY26: a −2-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
−263 days vs FY21
Cash cycleInventory daysDebtor daysPayable days
46634021589−37days−2d153d59d214dFY14FY17FY20FY23FY26
46634021589−37days−2d153d59d214dFY14FY20FY26

On the investment side: capital spending of ₹91.0 Cr over the last 3 fiscal years against ₹48.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹51.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹71.0 Cr, work-in-progress ₹51.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
92674217−8₹ Cr₹71₹51FY16FY18FY21FY23FY26
92674217−8₹ Cr₹71₹51FY16FY21FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Welspun Specialty Solutions Ltd earns a ROCE of 10% in FY26. That is up from a trough of −33% in FY20. Return on invested capital clears the cost of that capital by −1.4 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 2.6% net margin on 1.02× asset turns.

FY26 ROCE is 10%, recovered from a FY20 trough of −33% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY26): 2.6% net margin × 1.02× asset turns × 1.91× balance-sheet leverage ≈ 5.1% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 10.6% − 12.0% = a −1.4 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY26: ROCE 10% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 13-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY20's −33%
ROCEROIC (annual)WACC
24%8.9%−6.5%−22%−37%%10%8.6%FY14FY20FY26
24%8.9%−6.5%−22%−37%%10%8.6%FY14FY20FY26
Q4 FY26: ROCE 6.5% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
24%18%13%7.3%1.7%%6.5%7.5%Q2 FY24Q3 FY25Q1 FY27
24%18%13%7.3%1.7%%6.5%7.5%Q2 FY24Q3 FY25Q1 FY27
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Welspun Specialty Solutions Ltd carries total debt of ₹35.0 Cr against shareholder equity of ₹457 Cr as of Jun 26, a debt-to-equity of 0.08 — effectively unlevered. On the annual view that ratio went from 5.48 in FY22 to 0.08 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Jun 26: total debt of ₹35.0 Cr against shareholder equity of ₹457 Cr — a debt-to-equity of 0.08. On the annual view, debt-to-equity went from 5.48 (FY22) to 0.08 (FY26). The returns on this page are earned, not borrowed.

FY26: debt ₹35.0 Cr at 0.08× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
2818.7×2116.4×1404.0×701.7×0−0.6×₹ Cr×₹350.08×FY22FY24FY26
2818.7×2116.4×1404.0×701.7×0−0.6×₹ Cr×₹350.08×FY22FY24FY26
Jun 26: debt ₹35.0 Cr, debt-to-equity 0.08 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
3275.0×2453.7×1642.3×821.0×0−0.3×₹ Cr×₹350.08×Sep 23Dec 24Jun 26
3275.0×2453.7×1642.3×821.0×0−0.3×₹ Cr×₹350.08×Sep 23Dec 24Jun 26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Foreign institutions added 1.3 points of Welspun Specialty Solutions Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 1.3% of the company. Domestic institutions moved +0.1 points over the same window, to 0.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: +1.3 points over 8 quarters to 1.3%; Domestic institutions: +0.1 points over 8 quarters to 0.1%; Promoters: +0.0 points over 8 quarters to 55.2%.

Why the register moved: foreign institutions drove it (+1.3 points) — steady accumulation by institutions reading the same numbers this page reads.

Fiscal-year ends: promoters +0.0 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
60%44%28%12%−4.4%%55.2%1.3%0%43.5%Mar 24Mar 25Mar 26
60%44%28%12%−4.4%%55.2%1.3%0%43.5%Mar 24Mar 25Mar 26
Foreign institutions added 1.3 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
60%44%28%12%−4.4%%55.2%1.3%0.1%43.5%Jun 23Dec 24Jun 26
60%44%28%12%−4.4%%55.2%1.3%0.1%43.5%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Welspun Specialty Solutions Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Steel - Tubes/Pipes
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Sambhv Steel Tubes LtdSAMBHV 67.7/100Favorable setup73% evidence ASLEEP 30.6/35 Revenue 60.4% · PAT 195.8% · OPM change 3 pp 88% evidence 15.5/25 ROCE 19.4% · OPM 13% 100% evidence 10.0/20 P/E 24.4× · PEG — 15% evidence 11.6/20 RS sector -1.5% · RS bench 9.1% · 1Y -9.5%6 of 12 weeks ahead 70% evidence
Exact sum: 30.6 + 15.5 + 10 + 11.6 = 67.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2DEE Development Engineers LtdDEEDEV 64.0/100Mixed-positive evidence89% evidence LEADER 23.8/35 Revenue 38.2% · PAT 77.3% · OPM change -4 pp 88% evidence 7.8/25 ROCE 10.9% · OPM 18% 100% evidence 12.4/20 P/E 64.7× · PEG 0.62 65% evidence 20.0/20 RS sector 74.7% · RS bench 87.6% · 1Y 127.2%12 of 12 weeks ahead 100% evidence
Exact sum: 23.8 + 7.8 + 12.4 + 20 = 64 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3APL Apollo Tubes LtdAPLAPOLLO 62.5/100Mixed-positive evidence100% evidence ASLEEP 25.7/35 Revenue 10.4% · PAT 53.4% · OPM change 0 pp 100% evidence 17.8/25 ROCE 31.6% · OPM 7% 100% evidence 14.4/20 P/E 41.1× · PEG 0.7 100% evidence 4.6/20 RS sector -14% · RS bench -3.9% · 1Y 17.9%0 of 12 weeks ahead 100% evidence
Exact sum: 25.7 + 17.8 + 14.4 + 4.6 = 62.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -14% and the one-year return is 17.9%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
4Venus Pipes & Tubes LtdVENUSPIPES 62.0/100Mixed-positive evidence96% evidence LEADER 15.6/35 Revenue 21.8% · PAT 9.6% · OPM change 0 pp 88% evidence 21.1/25 ROCE 22.5% · OPM 16% 100% evidence 6.5/20 P/E 33.7× · PEG 3.42 100% evidence 18.8/20 RS sector 14.9% · RS bench 26.5% · 1Y 13.4%12 of 12 weeks ahead 100% evidence
Exact sum: 15.6 + 21.1 + 6.5 + 18.8 = 62 · Decision use: Price leads the evidence: RS versus the benchmark is 26.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
5Gandhi Special Tubes LtdGANDHITUBE 61.2/100Mixed-positive evidence83% evidence TURNING 23.0/35 Revenue 11.2% · PAT 16.5% · OPM change 4.3 pp 83% evidence 18.7/25 ROCE 28.4% · OPM 41.3% 95% evidence 10.9/20 P/E 18.4× · PEG — 50% evidence 8.6/20 RS sector -6.7% · RS bench 3.5% · 1Y 16.5%2 of 12 weeks ahead 100% evidence
Exact sum: 23 + 18.7 + 10.9 + 8.6 = 61.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Goodluck India LtdGOODLUCK 59.4/100Mixed-positive evidence96% evidence LEADER 18.7/35 Revenue 4.1% · PAT 10.2% · OPM change 2 pp 88% evidence 13.0/25 ROCE 14.4% · OPM 10% 100% evidence 10.7/20 P/E 27.9× · PEG 0.51 100% evidence 17.0/20 RS sector 12.2% · RS bench 23.9% · 1Y 45.3%12 of 12 weeks ahead 100% evidence
Exact sum: 18.7 + 13 + 10.7 + 17 = 59.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Man Industries (India) LtdMANINDS 54.8/100Mixed-positive evidence96% evidence FADING 16.9/35 Revenue 1.6% · PAT 11.8% · OPM change 2 pp 88% evidence 14.3/25 ROCE 16.2% · OPM 12% 100% evidence 12.3/20 P/E 23.4× · PEG 0.2 100% evidence 11.3/20 RS sector 6.9% · RS bench 17.6% · 1Y 24.9%9 of 12 weeks ahead 100% evidence
Exact sum: 16.9 + 14.3 + 12.3 + 11.3 = 54.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Hariom Pipe Industries LtdHARIOMPIPE 54.4/100Mixed-positive evidence70% evidence TURNING 21.3/35 Revenue 22.8% · PAT 22.6% · OPM change 1 pp 83% evidence 15.6/25 ROCE 15.7% · OPM 13% 95% evidence 11.3/20 P/E 16× · PEG — 15% evidence 6.2/20 RS sector -14.3% · RS bench -2.6% · 1Y -14.3%8 of 10 weeks ahead 70% evidence
Exact sum: 21.3 + 15.6 + 11.3 + 6.2 = 54.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9Welspun Specialty Solutions Ltdthis pageWELSPLSOL 50.5/100Mixed-positive evidence74% evidence LEADER 20.3/35 Revenue 15.2% · PAT 100% · OPM change 3.3 pp 74% evidence 4.9/25 ROCE 9.9% · OPM 5.4% 100% evidence 8.5/20 P/E 118× · PEG — 15% evidence 16.8/20 RS sector 13.9% · RS bench 25.7% · 1Y 55.1%12 of 12 weeks ahead 100% evidence
Exact sum: 20.3 + 4.9 + 8.5 + 16.8 = 50.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Scoda Tubes LtdSCODATUBES 49.6/100Mixed-negative evidence61% evidence ASLEEP 13.9/35 Revenue 7% · PAT 22.3% · OPM change -0.6 pp 83% evidence 16.7/25 ROCE 16.5% · OPM 13.5% 95% evidence 10.5/20 P/E 22.6× · PEG — 15% evidence 8.5/20 RS sector — · RS bench -4.6% · 1Y -24.3%2 of 10 weeks ahead 25% evidence
Exact sum: 13.9 + 16.7 + 10.5 + 8.5 = 49.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11JTL Industries LtdJTLIND 44.4/100Mixed-negative evidence96% evidence FADING 18.1/35 Revenue 11.5% · PAT 4% · OPM change 4.2 pp 88% evidence 5.8/25 ROCE 9.6% · OPM 8% 100% evidence 11.7/20 P/E 29.2× · PEG 1.27 100% evidence 8.8/20 RS sector -1.6% · RS bench 8.8% · 1Y -2.3%10 of 12 weeks ahead 100% evidence
Exact sum: 18.1 + 5.8 + 11.7 + 8.8 = 44.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Hi-Tech Pipes LtdHITECH 39.1/100Mixed-negative evidence77% evidence ASLEEP 16.5/35 Revenue 36.9% · PAT 4.1% · OPM change -1.7 pp 83% evidence 7.0/25 ROCE 9.8% · OPM 3.1% 95% evidence 10.1/20 P/E 22.6× · PEG — 50% evidence 5.5/20 RS sector -9.4% · RS bench -9.4% · 1Y -8.4%3 of 10 weeks ahead 70% evidence
Exact sum: 16.5 + 7 + 10.1 + 5.5 = 39.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Maharashtra Seamless LtdMAHSEAMLES 35.5/100Mixed-negative evidence78% evidence ASLEEP 7.6/35 Revenue -11.3% · PAT -9.8% · OPM change -2 pp 83% evidence 13.6/25 ROCE 14.3% · OPM 18% 76% evidence 12.2/20 P/E 10.8× · PEG — 50% evidence 2.1/20 RS sector -15.1% · RS bench -5.8% · 1Y -19.9%4 of 12 weeks ahead 100% evidence
Exact sum: 7.6 + 13.6 + 12.2 + 2.1 = 35.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Surya Roshni LtdSURYAROSNI 27.2/100Adverse evidence90% evidence ASLEEP 6.6/35 Revenue 1.4% · PAT -17.3% · OPM change -2 pp 88% evidence 12.6/25 ROCE 15.8% · OPM 7% 100% evidence 4.1/20 P/E 18.2× · PEG 4.08 100% evidence 3.9/20 RS sector -17% · RS bench -8.4% · 1Y -29%7 of 10 weeks ahead 70% evidence
Exact sum: 6.6 + 12.6 + 4.1 + 3.9 = 27.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Rama Steel Tubes LtdRAMASTEEL 22.4/100Adverse evidence77% evidence ASLEEP 7.5/35 Revenue 7.3% · PAT -49.3% · OPM change -2.4 pp 83% evidence 4.0/25 ROCE 5.6% · OPM 1.7% 95% evidence 7.9/20 P/E 53.7× · PEG — 50% evidence 3.0/20 RS sector -48.6% · RS bench -46.7% · 1Y -63.2%0 of 10 weeks ahead 70% evidence
Exact sum: 7.5 + 4 + 7.9 + 3 = 22.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Welspun Specialty Solutions Ltd's share price today?

Welspun Specialty Solutions Ltd trades at ₹51.0, +55.7% over the past year. The company is valued at ₹3,384 Cr. The stock sits at 68% of its 52-week range of ₹32–₹60, +18.6% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 13 weeks in. — as of 31 July 2026.

What were Welspun Specialty Solutions Ltd's latest quarterly results?

Welspun Specialty Solutions Ltd reported revenue of ₹194 Cr and net profit of ₹5.2 Cr for the Jun 26 quarter. Earnings per share were ₹0.08. The operating margin was 5.4%, 3.3 pp higher than a year earlier. — as of 31 July 2026.

What is Welspun Specialty Solutions Ltd's revenue?

Welspun Specialty Solutions Ltd reported revenue of ₹194 Cr in the Jun 26 quarter, −3.8% year on year. For the full FY26 fiscal year, revenue was ₹886 Cr (+22.4%). Over the last 10 years revenue compounded at 12.7% a year. — as of 31 July 2026.

What is Welspun Specialty Solutions Ltd's profit?

Welspun Specialty Solutions Ltd earned ₹5.2 Cr of net profit in the Jun 26 quarter. Full-year FY26 profit was ₹23.0 Cr. The operating margin ran 5.4% in the latest quarter. — as of 31 July 2026.

What is Welspun Specialty Solutions Ltd's market cap?

Welspun Specialty Solutions Ltd's market capitalisation is ₹3,384 Cr at a share price of ₹51.0. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.

What is Welspun Specialty Solutions Ltd's P/E ratio?

Welspun Specialty Solutions Ltd trades at a P/E of 118.0×, at the 59th percentile of its own 3-year range, against a long-run median of 104.5×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.

Does Welspun Specialty Solutions Ltd pay a dividend?

No — Welspun Specialty Solutions Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.

Is Welspun Specialty Solutions Ltd overvalued?

On its own history, Welspun Specialty Solutions Ltd looks mid-range against its own history: its P/E of 118.0× sits at the 59th percentile of its 3-year range (long-run median 104.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.

How is Welspun Specialty Solutions Ltd performing?

Welspun Specialty Solutions Ltd is in a confirmed uptrend, 13 weeks in. Against the NIFTY 500 it has been behind on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 31 July 2026.

Is Welspun Specialty Solutions Ltd in an uptrend?

Yes — the price is in a confirmed uptrend (week 13 of stage 2), trading +18.6% versus its 200-day average and at 68% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.

Is Welspun Specialty Solutions Ltd beating the market?

Not lately — on a trailing-13-week view Welspun Specialty Solutions Ltd is currently behind the NIFTY 500 (1 week and counting; last ahead the week of 2026-07-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +1,362% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.

Will Welspun Specialty Solutions Ltd's share price go up?

This page publishes no price forecast for Welspun Specialty Solutions Ltd. What it measures instead: the share price is ₹51.0, the price is in a confirmed uptrend 13 weeks in. Its P/E of 118.0× sits at the 59th percentile of its own 3-year range. — as of 31 July 2026.

Who owns Welspun Specialty Solutions Ltd?

Promoters hold 55.2% of Welspun Specialty Solutions Ltd, foreign institutions 1.3%, domestic institutions 0.1% and the public 43.5% (latest quarter). The biggest move on the register over the last two years: Foreign institutions added 1.3 points over 8 quarters. — as of 31 July 2026.

Does Welspun Specialty Solutions Ltd have too much debt?

No — Welspun Specialty Solutions Ltd's debt-to-equity is 0.08, and operating profit covers the interest bill 2×. FY26 borrowings were ₹35.0 Cr against equity of ₹457 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.

What is Welspun Specialty Solutions Ltd's capex?

Welspun Specialty Solutions Ltd spent ₹91.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹71.0 Cr, with ₹51.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.

What is Welspun Specialty Solutions Ltd's cash flow?

Welspun Specialty Solutions Ltd generated ₹128 Cr of operating cash flow in FY26 and ₹57.0 Cr of free cash flow after ₹71.0 Cr of capital spending. Reported profit that year was ₹23.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.

Is Welspun Specialty Solutions Ltd's profit real cash?

Yes — over the last 3 fiscal years, 100% of Welspun Specialty Solutions Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹128 Cr against reported profit of ₹23.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.

Where is Welspun Specialty Solutions Ltd in its business cycle?

Welspun Specialty Solutions Ltd's FY26 operating margin was 5.0%, against a 13-year band of −24.0%–8.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 5.4%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.

What could break the Welspun Specialty Solutions Ltd story?

Biggest watch item: the price is already 13 weeks into its uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.

Is Welspun Specialty Solutions Ltd a stock worth studying right now?

This is not investment advice. The machine read: Welspun Specialty Solutions Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI